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Results: The mean GTV volumes ranged from 149.44 to 
526.53 cc. VMAT plans show good results in comparison with 
3DCRT in both conformity index (0.81±0.09 Vs 0.68±0.07 
respectively, p-value of 0.009), and heterogeneity index 
(0.11±0.03 Vs 0.14±0.02, p value= 0.042). Furthermore, 
minimum doses to PTV in VMAT plans are higher than 3DCRT 
plans (57±1.22 Vs 55.1±0.86, p value= 0.001).  
In risk structures, the lung volume receiving 10Gy, 20Gy and 
30Gy were reduced in VMAT plans (with relative reduction of 
2.27%, p=0.002; 4.87%, p=0.001; 11.8% respectively). Mean 
lung dose was also reduced ( 15 Vs 17.69 ) but not 
statistically significant. V30 of the heart was reduced 
compared to 3DCRT (7.53±6.2 10.43±6.8 with p value of 
0.051). The maximum dose of esophagus with VMAT was 47.7 
Vs 48.69 with 3D CRT ( not statistically significant). 
Moreover, D 50 of the esophagus was less with VMAT ( 19.94 
Vs 23.63) with p value of 0.22. 
Regarding monitor units, the mean values were ( 
461.40±124.42 Vs 227.90±13.52) for VMAT and 3D CRT 
respectively.  
 
Conclusion: Inspite of large PTVs included in our study VMAT 
planes showed tendency toward reduction of mean and high 
lung dose and heart doses. Reduction in esophageal doses 
was not statistically significant , This was obtained without 
impairment of PTV coverage that was improved in some 
cases. VMAT for advanced lung cancer can help to improve 
therapeutic ratio and may open the door for dose escalation 
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Purpose or Objective: CSI is one of the most complex 
radiotherapy (RT) treatments. Conformal 3D RT techniques 
require many fields (field within field / segments) to achieve 
homogeneity and minimise doses to organs at risk (OAR) and 
involve field junctions. The planning process is time 
consuming and the actual treatment delivery is long, 
frequently exceeding 30 minutes. HT offers an excellent 
alternative with the ability to treat patients in supine 
position, without junctions and with better dose distribution. 
The aim of this study is to evaluate the use of HT in CSI with 
emphasis on dosimetric parameters and treatment duration. 
 
Material and Methods: Retrospective analysis of treatment 
planning and dosimetric indices was undertaken on seven 
patients who received cranio-spinal radiotherapy with HT at 
our centre. The HT plan was delivered using 51 beam angles 
per rotation, with a constant modulation factor of 2.0, field 
width of 5 cm and one of two pitches (0.43 or 0.28) to 
optimise treatment plans. An iterative inverse planning 
algorithm based on least squares minimization was used 
which optimises multi-leaf collimator at each beam angle. 
Dose was calculated by convolution and superposition. 
Patients were imaged daily covering different areas of the 
body and corrections applied for directional errors. Data 
analysis was done using descriptive statistics. 
 
Results: Helical tomotherapy plans for seven adult patients 
were analysed. Five patients had a haematological 
malignancy and two had a medulloblastoma. Five patients 
with a haematological diagnosis received a dose of 30Gy in 
1.5Gy/#. Two patients with medulloblastoma received 35 Gy 
delivered in 1.67Gy/#. Details of treatment planning and plan 
evaluation parameters of seven patients are presented in 
Table 1.  
 
 
Overall HT plans achieved excellent PTV coverage with mean 
V95 of 33.5 Gy for medullblastoma patients. The mean V95 
was 28.3 Gy for those with a haematological diagnosis. The 
mean homogeneity index was 1.0. Organs at risk doses were 
well below tolerances required. In particular averaged mean 
heart dose was 10.9±1.3, mean lung dose was 8.6±2.2 and 
mean liver dose was 9.8±1.2. The mean D50% for lung was 7.2 
Gy±3.8 and mean D10% was 20.2Gy±3.6. The mean D50% for 
the heart was 10.1Gy±1.3 and mean D10% was 14.7Gy±2.1. 
 
Conclusion: HT for CSI has many advantages including: the 
ability to treat patients in supine position, no need for 
junctions, excellent PTV coverage, low doses to OAR and 
shorter treatment time. 
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Purpose or Objective: Stereotactic radiosurgery of brain 
metastases requires highly conformal dose distributions. 
Besides beams setup, characteristics of the linear accelerator 
collimator may also play a role. In this study we compared 
the impact of leaf width on the dose outside the target for 
stereotactic radiosurgery of single brain metastases. 
 
Material and Methods: For 10 patients with one lesion, 
treatment plans were generated using two MLC types: Elekta 
Agilty with 0.5cm leaf width and Elekta MLCi2 with 1cm leaf 
width. Two VMAT arcs were used, one coplanar arc and one 
non-coplanar arc (couch 90˚). Five patients had a PTV 
volume ≤ 4 cm³ with a prescription dose of 24Gy in 1 
fraction, and 5 patients had a PTV volume between 4 and 14 
cm³ with a prescription dose of 18Gy in 1 fraction. All plans 
were required to fulfill clinical requirements: 
V100%Dpres>95%VPTV, D0<150%Dpres and OAR doses as low 
as possible and never above clinical constraints. The 
maximum dose in the PTV is kept the same per patient in 
both plans. The quality of the dose distribution outside the 
PTV was evaluated using the mean dose in two ring 
structures, adjacent to the PTV. 
 
Results: The mean dose was evaluated in the first 2 rings of 5 
mm around the PTV(table 1). The difference in mean dose for 
the small lesions(Dpres=24 Gy) of the first ring of 5 mm is 1.8 
Gy in favor of the Agility and 0.9 Gy for the larger 
lesions(Dpres=18 Gy)also in favor of the Agility. The 
difference is smaller for the larger lesions (figure1). Also for 
the second ring of 5 mm, adjacent to the first ring, the 
difference is is 1.1 Gy vs 0.8 Gy also in favor of the Agility.  
 





Conclusion: For the small lesions with a volume smaller than 
4 cm³ the Agility shows a steeper gradient in the two 
surrounding rings than the MLCi1. Therefore we recommend 
the use of the Agility for treating the smaller lesions.  
 
EP-1681  
A treatment planning strategy for SBRT of multiple T1-2 
lung tumors 
A. Tijhuis
1The Netherlands Cancer Institute, Department of Radiation 
Oncology, Amsterdam, The Netherlands 
1, E. Van der Bijl1, J. Knegjens1, C. Van Vliet-
Vroegindeweij1, E. Damen1 
 
Purpose or Objective: To obtain a planning technique for 
SBRT treatment of multiple lung tumors, which is suitable for 
all relative positions of the tumors. 
 
Material and Methods: For 10 patients with two tumors, 
treated with 3 x 18Gy, VMAT plans were generated in 
Pinnacle, using various approaches: simultaneous versus 
sequential optimization, with or without the dose distribution 
of one tumor as background for optimization of the other 
tumor. The quality of the treatment plans was judged on 
coverage (PTV V100% >95%), conformity (V100%/PTV volume), 
inhomogeneity (PTV D0<165%) and dose constraints on OARs.  
 
Results: Simple addition of beams for two independently 
planned tumors does not yield optimal results since the 
mutual low dose contributions cannot be taken into account 
properly. Simultaneous optimization on both targets results 
in pairs of open leafs in-between the lesions (Fig 1). We 
therefore concluded that the strategy that yields the most 
conformal plans is the subsequent planning of the tumors 
using a dual-arc for both, where the dose distribution 
resulting from the planning of the first target is used as a 
background dose while optimizing the beams for the second 
target. During optimization of the first tumor, no limit is 
applied for the dose to the second PTV, since this can be 
compensated for in the optimization procedure for this PTV. 
After optimization of the second PTV, the number of monitor 
units in each beam pair might be adjusted slightly to conform 
to the required target coverage. This strategy works for two 
or more isocenters as well as for one mutual isocenter. For 




Conclusion: We developed a generic planning strategy to 
obtain high quality lung SBRT-treatment plans for patients 
with multiple lung tumors. The strategy uses a dual-arc VMAT 
for each tumor, while taking the dose distribution covering 
the first target is used as background during dose 
optimization for the second target. This method is clinically 
in use since March 2015, since then 15 patients have been 
treated using this method. 
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Purpose or Objective: Two centers compared 
VMAT/RapidArc (RA) and Tomotherapy (TOMO). for the 
irradiation of breast and regional lymph nodes. 
 
Material and Methods: Five left and five right breasts plus 
regional nodes have been contoured by two dedicated 
radiation oncologists. Two senior physicists checked the 
treatment plans studied by dedicated dosimetrists. The 
Anatom-e tool was tested for improving definition and 
avoiding interpersonal variability in the contouring. 
Prescription, according to ICRU, was 50 Gy in 25 daily 
fractions. We considered both lungs, the heart, the left 
anterior descending coronary artery (LAD), the controlateral 
breast and the thyroid as Organa t Risk (OaR). The dose 
constraints were: PTV V95=95%, ipsilateral lung V20 ≤20%, 
heart mean dose < 10Gy, heart max dose <35Gy, LAD max 
dose ≤20Gy, thyroid max dose < 45 Gy and contralateral 
breast max dose≤5 Gy. We have studied the treatments in 
free breathing modality, perfectly aware of the higher dose 
received by heart and LAD in comparison to the respiratory- 
gated modality, routinely used in the RA center. 
 
Results: We summarized the results of this comparison in 
Table 1  




Conclusion: Both techniques allow a good coverage and dose 
uniformity for the PTV, with proper sparing of the OaR. TOMO 
